FDA Approves Cytokinetics’ Heart Drug, Giving It an Edge Over BMS Rival
Cytokinetics has achieved a significant milestone with the recent FDA approval of its heart drug,…
Newswire
JAX and NYSCF Launch Unified Organization to Accelerate Biomedical Research
The Jackson Laboratory (JAX) and the New York Stem Cell Foundation (NYSCF) have officially launched…
Cytokinetics Secures First FDA Approval for Heart Drug Myqorzo
It took 27 years, but Cytokinetics has achieved a significant milestone by securing its first…
Kennedy Vaccine Adviser William Thompson Promoted to Oversee CDC’s Childhood Health Research
WASHINGTON — William Thompson, a vaccine adviser at the Centers for Disease Control and Prevention…
Galux and Boehringer Ingelheim Agree to Design Purpose-Specific Protein Molecules
Galux, a South Korean biotech specializing in AI-driven protein therapeutics discovery, has entered into a…
Patient deaths put Merck, Daiichi’s ADC trial on partial hold
The FDA has imposed a partial hold on the clinical trial of I-DXd, a novel…
UnitedHealth Claims Robust Audit Findings Amid Contradictory Independent Reviews
UnitedHealth Group announced on Friday that its recent audits, conducted by hired consultants, reveal that…
White House Set to Announce Largest Batch of Drug Pricing Agreements Yet
WASHINGTON — Nine drugmakers are poised to unveil agreements with the Trump administration aimed at…
Post-Election Shifts in Health and Medicine Signal Unprecedented Changes Ahead
In a letter dated two days after the 2024 presidential election, STAT’s Rick Berke highlighted…
Galapagos’ Last Asset Posts Mixed Results as Future Remains in Flux
Galapagos has reported mixed results for its final asset, raising questions about the future direction…